which is activated in erythroblastic leukemias induced by the insertion of spleen focus-forming virus (SFFV) (7) .
Some of the genes thought to be regulated by PU.1 in lymphocytes include the Ig K light chain gene 3' enhancer (8, 9) , the Ig k 2-4 enhancer (10), the Ig heavy chain p, enhancer (11) , the IgJ chain gene (12) , and the rob-1 gene, which is expressed in early B cell differentiation (13, 14) . PU. 1 is believed to regulate the expression in macrophages of several receptors, which include the Fc',/RI~ gene (15) , the Fc~/PdlIA gene (16) , the M-CSF receptor gene (17) , the CD11b gene (18, 19) , the scavenger receptor (20) , the macrophage inflammatory protein lc~ (MIP-lo 0 (21), IL-113 (22) , and CD18 (23) . Recently, it has been shown that PU.1 interacts with the B cell--specific factor NF-EM5 (Pip) and stimulates transcription from the Ig K 3' enhancer (7, 24) .
Using the technique of gene targeting, mice homozygous for the disruption of the PU.1 gene have been generated. Scott et al. (25) (26) concluded that PU.1 is not essential for early myeloid gene expression, but is required for terminal myeloid differentiation.
In the present study we demonstrate that PU.1 is involved in macrophage proliferation. Transfection of a PU. 1 expression construct into bone marrow macrophages was found to stimulate both M-and GM-CSF-dependent proliferation of these cells, whereas transfection ofa PU.1 antisense construct or a construct that expressed DNA-binding domain of PU.1 into bone marrow macrophages was found to inhibit the proliferative effect of the growth factors. Thus, PU.1 seems to regulate the expression of genes involved within macrophage proliferation.
Materials and Methods
Mouse Bone Marrow-derived Macrophages. Macrophages derived from bone marrow cultures (BMDM) 1 were obtained as described (27) . 6-wk-old DBA/2 mice (The Jackson Laboratory, Bar Harbor, ME) were killed by cervical dislocation, and both femurs were dissected free of adherent tissue. The ends of the bones were cut off and the marrow tissue was eluted by irrigation with PBS. Cells were suspended by vigorous pipetting, washed once in PBS, and collected by centrifugation. We cultured 107 cells in a plastic, nontissue culture, 150-ram petri dish (Lab-Tek 4030; 1Abbreviations used in this paper: BMDM, bone marrow-derived macrophages; LCM, L cell-conditioned medium; PEST, proline (P), glutamic acid (E), serine (S), and threonine (T).
Miles Laboratories, Inc., Naperville, IL) in 50 ml of DME containing 2 mM L-glutamine, 1 mM Na pyruvate, 50 U/ml penicillin, 50 mg/ml streptomycin, 20% FCS, and 30% L cell-conditioned medium (LCM) as a source of M-CSF. The cell suspensions were incubated at 37~ in a humidified 5% C02 atmosphere. Macrophages were loosely adherent to the dishes and were harvested with cold PBS. In some experiments, serum-free media composed of CMRL-1066, insulin, glutamine, transferrin (GIBCO BILL, Gaithersburg, MD), and sodium bicarbonate, were used.
Cultured Cell D'nes. The mufine fibrosarcoma L929 and the murine macrophage cell fines RAW264.7, IC-21, and BAC1 2F5-A were maintained in DME supplemented with 2 mM L-glutamine, 50 U/ml penicillin, 50 mg/ml streptomycin, 1 mM Na pyruvate, and 5% FCS.
Proliferation Assay. Cell proliferation was measured as previously described (28) with minor modifications. After electroporation, cells (5 • 10 s) were incubated for 24 h in 24-well plates (3424 MARK II; Costar Corp., Cambridge, MA) in 1 ml of media with the indicated growth factor. For the experiments with oligodeoxynucleotides, 5 • 104 BMDM were incubated in 96-well plates with 100 ml of media containing M-CSF for 2 h. Media were aspirated and replaced by 0.2 ml of media containing [3H]thymidine (1.0 mCi/ml). After an additional 2 h of incubation at 37~ media were removed and cells were fLxed in methanol. After three washes in 10% TCA, cells were solubilized in 1% SDS and 0.3 M NaOH. Radioactivity was counted by liquid scintillation. All samples were prepared in triplicate and the results are expressed as the mean value. In some experiments, cells were trypsinized and counted with a Coulter counter (ZM model; Hialeah, FL). Each experiment was performed at least five times and the results are expressed as the mean + SD. Statistical analyses were performed using the Student's paired t test, comparing the results of at least five independent experiments.
Transfections. Cells were removed from plates and washed twice in serum-free media. Cells were then incubated (12 3< 10 ~' in 1 ml of serum-free media) at 4~ in the cuvettes used for electroporation, with 2 p~g of DNA for 15 rain. Electroporation was carried out using a BTX electroporator (Transfector 100; Biotechnologies & Exp. Research, San Diego, CA). Cells were incubated for a further 15 rain on ice before they were distributed in 24-well plates. To determine the transfection efficiency in some experiments, we transfected an expression construct containing the green fluorescent protein gene (Clontech, Palo Alto, CA). After 2 d of culture, cells were fixed, stained, and counted (29) .
In a series of preliminary experiments, we tested the appropriate conditions for transfection using the electroporation method (10 ms at 200 mV). We also found that increasing the amount of DNA transfected (any type) in BMDM resulted in a concentration-dependent decrease in proliferation. Therefore, we chose conditions that optimized the number of cells transfected, but also permitted proliferation. The amount of DNA used was 2 mg for 12 • 106 cells, which resulted in 7-12% of cells being transfected, as assessed by staining for green fluorescent protein.
Plasmids and Oligodeoxynucleotides. The PU.1 expression vector, PUpECE, was constructed by ligating the full-length PU.1 cDNA into the EcoR1 site of the expression vector, pECE (30) . The retinoic acid receptor e/a3 pECE was a gift from M. Pfahl (La Jolla Cancer Research Foundation) (31) . The PU.1 antisense construction was made by inserting the PU.I cDNA into the HindlII -Sal sites of the pHb APr-l-neo vector in the reverse orientation (32) .
The pBluescript KS+ vector was purchased from Stratagene, Inc. (La Jolla, CA), and the pBL CAT vector was obtained from Luckow and Schultz (33) . Phosphodiester ohgodeoxynucleotides were prepared using a DNA synthesizer (Model 380A; Applied Biosystems, Inc., Foster City, CA) and purified as described previously (34) . The PU.1 antisense (5'-TTTGCACGCCTGTAA-CATCCAGCTGACCTC-3') ohgodeoxynucleotide synthesized for these studies straddled the predicted translation-initiation site of the PU. 1 mRNA. A computer-assisted search of the GenBank database for mammalian sequences complementary to these antisense oligodeoxynucleotides revealed little homology with other genes.
Specific sites in the PU.1 gene were mutagenized using oligonucleotides spanning the desired site and a nearby unique restriction site, and generating the new fragment using the polymerase chain reaction. DNA fragments were isolated, the fragment was inserted into the PU.1 eukaryotic expression plasmid PUpECE previously described, and the DNA sequence was determined (8) . The plasmids containing the DNA-binding domain (170-260) or the proline (P), glutamic acid (E), serine (S), and threonine (T) rich region (PEST) deletion (126-159) of PU.1 have been previously described (8) . The plasmids containing ets-2 and fli-1 in the pECE vector have been previously described (35) .
Growth Factors and Interleukins. Recombinant growth factors were a gift from DNAX (Palo Alto, CA). In some experiments we used LCM as a source of M-CSF. The amount of M-CSF present in LCM was determined using a M-CSF standard. The growth activity of LCM could be blocked by a specific mAb against M-CSF. The M-CSF blocking antibody was a gift from Dr. H.S. Lin (Washington University School of Medicine, St. Louis, MO) (36) .
Determination of M-CSF Receptors on the Cell Surface.
The deterruination of M-CSF receptors on the cell surface was performed using specific antibodies and cytoflurometer analysis as previously described (37) . Cells were washed three times in PBS and incubated with an excess of goat IgG (Sigma Chemical Co., St. Louis, MO) (250 mg/ml) to block Fc receptors. After 30 rain at 4~ cells were washed, the primary antibody (rabbit anti-mouse c-fins; Upstate Biotechnology Inc., Lake Placid, NY) was added at a 1/200 dilution, and cells were incubated for 45 min at 4~ Finally, cells were incubated with fluorescein-conjugated goat affinity-purified F(ab')2 fragment to rabbit IgG (Cappel, Turhout, Belgium) at a dilution of 1/500, as recommended by the supplier, for 30 rain at 4~ Cytometry analysis was carried out using an Epics Ehte (Coulter Corp., Hialeah, FL) apparatus.
Results
The transcription factor PU. 1 has been hnked to the immortalization of erythroblasts, and may be involved in the regulation of a number of genes in macrophages, some of which are involved in development or growth control. To examine its role in this latter process, we designed both antisense and sense expression constructs of PU.1 and transfected these constructs into BMDM. The cells were grown from bone marrow cells cultured in the presence of M-CSF for 5-7 d, which promotes the prohferation of macrophages but not other cell types. After 5-7 d, the BMDM were transfected with either the PU.1 antisense construct PU.I-pHb or the pHb vector alone and replated in media containing various concentrations of M-CSF. The transfection efficiency was estimated to be between 7 and 12% based on the transfection of a green fluorescent protein ex- pression construct. BMDM transfected with the antisense PU.1 construct in the presense of M-CSF had a significantly reduced thymidine incorporation compared with the controls in which the vector alone was transfected into the cells (Fig. 1 A) . The experiment was repeated using an antisense oligonucleotide made complementary to a region that included the initiation codon of PU. 1. A sense oligonucleotide to the same region was made as a control. We observed that the antisense but not the sense oligonucleotide inhibited BMDM thymidine incorporation in a dosedependent manner that was dependent on the concentration of M-CSF in the media (Fig. 1 B) .
These results suggested that a block in the expression of PU.1 may inhibit macrophage proliferation. If this were the case, we reasoned that the overexpression of PU. 1 may stimulate proliferation. To test this possibility, we generated a sense construct of PU. 1, PU. 1-pECE and proceeded to analyze the effect of the overexpression of PU.1 on the M-CSF--stimulated proliferation of BMDM. In the presence of M-CSF, the number of BMDM was significantly higher when the BMDM were transfected with PU. 1 compared with the BMDM that were transfected with the vector alone (Fig. 2) . This result was also confirmed using thymidine incorporation as an index ofmacrophage proliferation. Thymidine incorporation was higher in BMDM treated with M-CSF and transfected with the PU.1 expression construct when compared with BMDM treated with M-CSF and transfected with vector alone (Fig. 3) .
To determine whether PU.1 acts as a general factor in macrophage proliferation, we incubated macrophages transfected with PU.1 or the control vector (pECE) in the presence of several recombinant growth factors or interleukins (Fig. 3) . We observed an increase in thymidine incorporation to varying degrees in BMDM treated with M-CSF, GM-CSF, IL-3, IL-1, IL-4, and IL-6 compared with the control. No difference in thymidine incorporation compared with controls was found when cells were cultured in the presence of either G-CSF or IL-2. When macrophages were transfected with an expression construct containing PU. 1, a significant increase in thymidine incorporation was observed only in cells treated with M-CSF or GM-CSF. These data suggest that PU.1 is involved in the regulation of macrophage proliferation that is M-CSF or GM-CSF dependent.
GM-CSF is known to induce the expression of M-CSF (38) (39) (40) (41) . To determine whether the increase in proliferation that we observed with the addition of GM-CSF to the cultures was due to the production of M-CSF, we added a mAb made against M-CSF to the culture media. The addition ofanti-M-CSF antibodies caused a substantial decrease (30%) in BMDM proliferation in cells transfected with control vector alone. This may be due to the inhibition of the autocrine production of M-CSF induced by GM-CSF. We observed that in the presence of the mAb against M-CSF there was no stimulation ofthymidine incorporation above background when GM-CSF was added to the cultures and the PU.1 expression construct transfected into the cells (Fig. 4) . These data suggest that the enhancement of GM-CSF-dependent proliferation in PU.l-transfected macrophages may be related to the autocrine production of M-CSF (38) (39) (40) (41) .
The effect of PU. i on proliferation appears to be linked to the growth factor-stimulated proliferation ofM-CSF. PU. 1 has been shown to bind to the promoter of the M-CSF receptor and therefore may be an important factor for the regulated expression of this receptor (17, 42) . To address this possibility, we transfected BMDM with a PU. 1 sense, antisense construct or vector alone as a control and measured the level of M-CSF receptor surface expression by flow cytometry. BMDM transfected with the vector alone were found to contain two populations of cells expressing the M-CSF receptor, one of which presented more receptors than the other (Fig. 5 ). Because these cells were proliferating, the heterogeneity in the number of M-CSF receptors may be related to the different stages of the cell cycle. The BMDM transfected with the sense PU.1 vector showed a marked increase in the population of ceils with O O CONTROL VECTOR the higher number of receptors. In contrast, the BMDM transfected with the antisense PU.1 construct showed a reduction of the same cell population (Fig. 6 ). Similar results were obtained when antisense oligonucleotides were used (data not shown). Thus, PU.1, which has been shown to bind the M-CSF promoter and regulate expression from this promoter using a reporter construct, is also involved in the regulation of M-CSF receptor expression in macrophages in vivo. Transfection of PU.1 into BMDM in the absence of M-CSF had no effect on the proliferation of the macrophages, suggesting that the effect of the antisense and sense PU. 1 constructs was growth factor dependent. We therefore wanted to know what effect PU.1 may have on M-CSFindependent proliferation. For this purpose we transfected a series of cell lines that are growth factor independent with PU. 1 in the sense or antisense orientation. The proliferation of three macrophage cell lines, IC-21, RAW264.7, and 2F5A, which express PU.1 endogenously, were tested using the sense and antisense constructs, and no effect on proliferation was observed (data not shown). These data suggest that PU. 1 is involved in a proliferative mechanism that is only present in growth factor-dependent macrophages.
Since PU.1 belongs to a large family of related DNAbinding proteins (Ets family) (43, 44), we were interested in determining whether the effect of PU.1 on macrophage proliferation was specific for PU.1, or whether other Ets family members could have the same effect on macrophage proliferation. Expression constructs of ets-2 and fli-1 were generated to test this possibility. When expression constructs containing either ets-2 or fli-1 were transfected into BMDM, no increase in macrophage proliferation above that seen using the vector alone was detected (Fig. 6) . Thus, we conclude that the effect of PU. 1 on macrophage proliferation is specific for PU. . The PEST domain has been shown to be important for the interaction ofPU. 1 with the B cell-specific factor NF-EM5 (Pip) (8, 24) . When a PU. 1 expression construct lacking the PEST domain was transfected into BMDM, an enhancement of macrophage proliferation similar to that obtained using the wild PU. 1 construction was observed, suggesting that the PEST domain was not important for this activity (Fig. 7 A) . A decrease in M-CSF-dependent proliferation, however, was observed when a PU.1 construct containing the DNAbinding domain (ETS domain) was transfected into the cells (Fig. 7 B) . The decrease in proliferation observed when the DNA-binding domain was used may be due to the competiton between the endogenous PU.1 and the transfected DNA-binding domain for a target sequence in a promoter or enhancer of a gene or genes involved in proliferation. Taken together, these data support the hypothesis that at least one of the functional activities of PU. 1 in macrophages is related to the control of genes involved in M-CSF-stimulated cell proliferation. The PU.1 transcription factor in routine macrophages is known to be phosphorylated on five serines that are consensus sites for casein kinase II (CK II) (9, and our unpublished results). The predicted serine CK II target sites in PU.1 were mutated to alanines and we examined whether the mutations had an affect on the ability of PU.1 transfected into BMDM to stimulate proliferation. PU.1 with the $132/133A or $148A mutations was as active as the wild-type protein in stimulating proliferation of BMDM (Fig. 7 B) . In contrast, PU.1 protein carrying an alanine substitution at $41 or $45 not only failed to stimulate proliferation, but also lowered the basal level of proliferation. The effect of the $41/45A double mutation was about the same as either of the single mutations. It is therefore likely, at least in macrophages, that phosphorylation of amino acids 41 and/or 45 results in the activation of a domain important for the activity of PU. 1.
Discussion
The data presented here indicate that PU. 1 is involved in macrophage proliferation. The block in macrophage proliferation using either an antisense PU. 1 expression construct or antisense oligonucleotides suggests that PU.1 plays a critical role in the proliferation of macrophages. The use of antisense oligonucleotides to inhibit gene expression and cell growth and development has provided new insight into the functional importance of a variety of genes (45) . Antisense ohgodeoxynucleotides of PU. 1 inhibit the proliferation of erythroleukemia cells induced by the retrovirus SFFV (46) . In this model, if the provirus integrates upstream of the PU.I gene, PU.1 is overexpressed and the cell loses its commitment to terminally differentiate and becomes immortal. A reduction in the expression of PU.1 coincides with recommitment to the program of erythroid differentiation and the loss of immortality (47) . The infection of erythroblasts with a retroviral vector expressing PU.1 was efficient for immortalization, suggesting that PU.1 perturbs the pathway that controls the potential for proliferation in these cells (48) .
The enhancement of macrophage proliferation induced by the transfection of PU.1 appears to be related to the presence of M-CSF in the media. This may explain why PU.1 is not effective in cell lines whose proliferation is independent of growth factors.
The effect of PU.1 protein seems to be specific because other ets family members such as ets-2 and fli-1 were ineffective in stimulating proliferation. The Ets family consists of a large number of proteins that have sequence identity within the DNA-binding domain, and all bind to a sequence containing the core sequence 5'-GGAA/T-3' (43). Whereas the core sequence appears to be necessary for binding it is known that flanking sequences also influence the binding of specific Ets family members to DNA (44, and our unpublished results). This may be part of the explanation for why PU.1 has an effect on macrophage proliferation, but not ets-2 or fli-1.
PU.1 functions in association with other factors (8, 10, 19, 49, 50) . In the mouse, K 3' enhancer for example, PU.1 recruits a B cell-restricted factor, NF-EM5 (Pip) (8, 24) . The protein-protein interaction is mediated through a 43--amino acid region with sequence homology to a PEST domain, i.e., one that is rich in proline (P), glutamic acid (E), serine (S), and threonine (T), which is susceptible to protease degradation (51) . The PEST sequence does not appear to have a role in the enhancement of macrophage proliferation by PU.1. However, expression of the PU.1 DNA-binding domain resulted in a reduced proliferation of BMDM. Dominant negative constructs of the PU.1 DNA-binding domain have proven useful in demonstrating the function of PU. 1 in regulating gene expression. A dominant negative expression construct of PU.1 in which aminos acids 133 to the end were expressed was used to show that PU. 1 was needed for expression from the J chain gene promoter (12) . A dominant negative PU.1 expression construct (amino acids 160-266) transfected into Rastransformed NIH3T3 fibroblasts reverted the transformed phenotype (52) . This latter result may be due to a general feature of the DNA-binding domains of ETS family members since dominant negative constructs of ets-1 and ets-2 had the same effect. The finding that mutations at serine 41 and 41/45 caused a lowering of proliferation in BMDM suggests that this region plays an important role for this activity. The NH2-terminal halfofPU.1 is known to be responsible for the transactivation properties of PU. 1 (our unpublished results). This may provide part of the explanation for the results seen with the serine 41 and 41/45 mutations.
The number of genes regulated by PU.1 that could modulate macrophage proliferation in response to M-CSF is at present unknown. Because the enhancement of proliferation requires the presence of the growth factor M-CSF, one possible candidate is the M-CSF receptor (c-fms), which is specifically expressed in macrophages (3) . Recently, it has been reported that PU.1 directs the expression of the M-CSF receptor (17, 42, 53) . PU.1 binds to a specific site in the M-CSF receptor promoter just upstream from the major transcription initiation site. Mutations at this site have been shown to eliminate PU.1 binding and decrease promoter activity. PU. 1 transactivates a reporter construct containing the M-CSF promoter. These experiments were performed by cotransfection in cells that normally do not express PU. 1 or the M-CSF receptor, with PU.1 cDNA and a reporter construct containing the M-CSF promoter (17) . It has also been reported that ets-2 transactivates the proximal promoter of the M-CSF receptor (42, 53) . In our experiments, ets-2 had no effect on M-CSF-dependent macrophage proliferation. This may be due to an already high level of ets-2 expression in the cells (our unpublished results).
PU. 1 is thought to regulate a number of other genes that could be involved in cell proliferation. For instance, PU.1 binds the tumor suppressor protein p53 which represses cell proliferation (49) . The inhibition of an inhibitor could result in the activation of proliferation. In vitro, PU.1 was also shown to interact with the general transcription factor TFIID (49) . PU.1 and PU.l-associated factor(s) could stabilize TFIID and allow assembly of the initiation complex of genes related to proliferation. However, the fact that enhancement of macrophage proliferation is M-CSF or GM-CSF dependent probably rules out this possibility.
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